Rockwell Medical (RMTI) CRUISE-1 Phase 3 Meets Primary and Secondary Endpoints
Tweet Send to a Friend
Rockwell Medical (NASDAQ: RMTI) announced successful top-line results from the long-term CRUISE-1 Phase 3 efficacy study of SFP. SFP is ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
